-
Loading metrics
Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study
- Derin Karacabeyli,
- Diane Lacaille,
- Na Lu,
- Natalie McCormick,
- Hui Xie,
- Hyon K. Choi,
- J. Antonio Aviña-Zubieta
x
- Published: August 8, 2024
- https://doi.org/10.1371/journal.pone.0308533